Published in J Crohns Colitis on April 10, 2009
Apremilast: a novel PDE4 inhibitor in the treatment of autoimmune and inflammatory diseases. Ther Adv Musculoskelet Dis (2010) 1.02
Phosphodiesterase 4-targeted treatments for autoimmune diseases. BMC Med (2013) 0.88
Mechanism of immunomodulatory drugs' action in the treatment of multiple myeloma. Acta Biochim Biophys Sin (Shanghai) (2013) 0.88
Matrix metalloproteinases in inflammatory bowel disease: an update. Mediators Inflamm (2015) 0.87
Frontiers in Drug Research and Development for Inflammatory Bowel Disease. Front Pharmacol (2017) 0.75
Small-molecule studies identify CDK8 as a regulator of IL-10 in myeloid cells. Nat Chem Biol (2017) 0.75
Recruitment of human muscleblind proteins to (CUG)(n) expansions associated with myotonic dystrophy. EMBO J (2000) 6.56
Childhood living conditions and Helicobacter pylori seropositivity in adult life. Lancet (1992) 6.28
Myotonic dystrophy in transgenic mice expressing an expanded CUG repeat. Science (2000) 5.85
Personal exposure monitoring of particulate matter, nitrogen dioxide, and carbon monoxide, including susceptible groups. Occup Environ Med (2002) 4.70
Muscleblind localizes to nuclear foci of aberrant RNA in myotonic dystrophy types 1 and 2. Hum Mol Genet (2001) 3.27
Relation of Helicobacter pylori infection and coronary heart disease. Br Heart J (1994) 3.13
Differential regulation of interleukin 17 and interferon gamma production in inflammatory bowel disease. Gut (2009) 2.48
Expanded CUG repeat RNAs form hairpins that activate the double-stranded RNA-dependent protein kinase PKR. RNA (2000) 2.25
Subcutaneous IGF-1 is not beneficial in 2-year ALS trial. Neurology (2008) 2.17
Expression profile of FSHD supports a link between retinal vasculopathy and muscular dystrophy. Neurology (2006) 2.14
Randomized controlled trial of IVIg in untreated chronic inflammatory demyelinating polyradiculoneuropathy. Neurology (2001) 1.88
Imbalance of stromelysin-1 and TIMP-1 in the mucosal lesions of children with inflammatory bowel disease. Gut (2000) 1.75
Increased enterocyte apoptosis and Fas-Fas ligand system in celiac disease. Am J Clin Pathol (2001) 1.74
Recent developments in the immunology of inflammatory bowel disease. Scand J Immunol (2000) 1.69
Mexiletine is an effective antimyotonia treatment in myotonic dystrophy type 1. Neurology (2010) 1.67
Inventory of high-abundance mRNAs in skeletal muscle of normal men. Genome Res (1999) 1.61
Enteral nutrition by nasojejunal tube in hyperemesis gravidarum. Clin Nutr (2001) 1.48
A comparison of teicoplanin versus cephradine plus metronidazole in the prophylaxis of post-operative infection in vascular surgery. J Hosp Infect (1999) 1.41
Enhancing Lamina propria Th1 cell responses with interleukin 12 produces severe tissue injury. Gastroenterology (1999) 1.41
Senescence-related changes in gene expression in muscle: similarities and differences between mice and men. Physiol Genomics (2001) 1.35
Ragged red fibers in normal aging and inflammatory myopathy. Ann Neurol (1995) 1.27
High-abundance mRNAs in human muscle: comparison between young and old. J Appl Physiol (1985) (2000) 1.23
Transforming growth factor beta signalling and matrix metalloproteinases in the mucosa overlying Crohn's disease strictures. Gut (2009) 1.22
T cells orchestrate intestinal mucosal shape and integrity. Immunol Today (1999) 1.21
Growth in infancy, infant feeding, childhood living conditions, and Helicobacter pylori infection at age 70. Arch Dis Child (1997) 1.19
Role of interferon alpha in promoting T helper cell type 1 responses in the small intestine in coeliac disease. Gut (2001) 1.19
Interactions between stromal cell--derived keratinocyte growth factor and epithelial transforming growth factor in immune-mediated crypt cell hyperplasia. J Clin Invest (1998) 1.19
Quantitative analysis of the "warm-up" phenomenon in myotonic dystrophy type 1. Muscle Nerve (2005) 1.18
Thalidomide in the treatment of cancer cachexia: a randomised placebo controlled trial. Gut (2005) 1.14
High-protein meals do not enhance myofibrillar synthesis after resistance exercise in 62- to 75-yr-old men and women. Am J Physiol (1998) 1.14
Human Peyer's patch T cells are sensitized to dietary antigen and display a Th cell type 1 cytokine profile. J Immunol (2000) 1.11
The immune recognition of gluten in coeliac disease. Clin Exp Immunol (2005) 1.10
Cancer cachexia. QJM (2005) 1.08
Quantitative assessment of motor fatigue and strength in MS. Neurology (1999) 1.08
Pleiotropic actions of miR-21 highlight the critical role of deregulated stromal microRNAs during colorectal cancer progression. Cell Death Dis (2013) 1.07
Surface hydrophobicity of gastric mucosa in peptic ulcer disease. Relationship to gastritis and Campylobacter pylori infection. Gastroenterology (1990) 1.05
Metal stents improve dysphagia, nutrition and survival in malignant oesophageal stenosis: a randomized controlled trial comparing modified Gianturco Z-stents with plastic Atkinson tubes. Eur J Gastroenterol Hepatol (1998) 1.04
The hypocretin neurotransmission system in myotonic dystrophy type 1. Neurology (2008) 1.03
Reduced cerebral blood flow and impaired visual-spatial function in proximal myotonic myopathy. Neurology (1999) 1.03
Stimulation of myofibrillar synthesis by exercise is mediated by more efficient translation of mRNA. J Appl Physiol (1985) (1999) 1.02
An introduction to Toll-like receptors and their possible role in the initiation of labour. BJOG (2007) 1.00
Interferon-alpha drives T cell-mediated immunopathology in the intestine. Eur J Immunol (2001) 1.00
Biomedicine. Reconstructing myotonic dystrophy. Science (2001) 0.99
Polycystic ovary syndrome and metabolic comorbidities: therapeutic options. Drugs Today (Barc) (2009) 0.99
Exposure of the fetus and infant to hens' egg ovalbumin via the placenta and breast milk in relation to maternal intake of dietary egg. Clin Exp Allergy (2005) 0.99
Ribonuclear foci at the neuromuscular junction in myotonic dystrophy type 1. Neuromuscul Disord (2007) 0.98
Collagenase-1 (MMP-1), matrilysin-1 (MMP-7), and stromelysin-2 (MMP-10) are expressed by migrating enterocytes during intestinal wound healing. Scand J Gastroenterol (2004) 0.98
Cytolytic mechanisms of intraepithelial lymphocytes in coeliac disease (CoD). Clin Exp Immunol (2000) 0.97
Kinetics of hepatic bile acid handling in cholestatic liver disease: effect of ursodeoxycholic acid. Gastroenterology (1994) 0.97
Determinants of pregnancy heartburn. Br J Obstet Gynaecol (1992) 0.96
Matrix metalloproteinases and their inhibitors in the nasal mucosa of patients with perennial allergic rhinitis. J Allergy Clin Immunol (2001) 0.96
The 'cut and push' method of percutaneous endoscopic gastrostomy tube removal. Clin Nutr (2000) 0.94
Neonatal interleukin-12 capacity is associated with variations in allergen-specific immune responses in the neonatal and postnatal periods. Clin Exp Allergy (2003) 0.93
Ovalbumin-specific immunoglobulin G and subclass responses through the first 5 years of life in relation to duration of egg sensitization and the development of asthma. Clin Exp Allergy (2004) 0.93
Leukocyte CTG repeat length correlates with severity of myotonia in myotonic dystrophy type 1. Neurology (2004) 0.92
Coeliac disease. Dig Liver Dis (2002) 0.91
A prospective natural history study of inclusion body myositis: implications for clinical trials. Neurology (2001) 0.91
Down-regulation of p38 mitogen-activated protein kinase activation and proinflammatory cytokine production by mitogen-activated protein kinase inhibitors in inflammatory bowel disease. Clin Exp Immunol (2010) 0.91
Lamina propria T cells. Chem Immunol (1998) 0.89
Safety of intravenous immunoglobulin. Arch Neurol (1993) 0.88
The administration of metformin during pregnancy reduces polycystic ovary syndrome related gestational complications. Eur J Obstet Gynecol Reprod Biol (2011) 0.87
Gliadin and tissue transglutaminase complexes in normal and coeliac duodenal mucosa. Clin Exp Immunol (2003) 0.87
A reassessment of splenic hypofunction in celiac disease. Am J Gastroenterol (1999) 0.87
Factor VIII-related antigen and factor VIII coagulant activity in normal and pre-eclamptic pregnancy. Br J Obstet Gynaecol (1977) 0.87
Interleukin-25 production is differently regulated by TNF-α and TGF-β1 in the human gut. Mucosal Immunol (2010) 0.86
Small bowel enterocyte apoptosis and proliferation are increased in the elderly. Gerontology (2002) 0.86
Thalidomide and its derivatives: emerging from the wilderness. Postgrad Med J (2003) 0.86
IL-15 positively regulates IL-21 production in celiac disease mucosa. Mucosal Immunol (2012) 0.85
Mechanisms of villous atrophy in autoimmune enteropathy and coeliac disease. Clin Exp Immunol (2002) 0.85
Role of macrophage metalloelastase in gut inflammation. Ann N Y Acad Sci (2006) 0.84
Serum ovalbumin-specific immunoglobulin G responses during pregnancy reflect maternal intake of dietary egg and relate to the development of allergy in early infancy. Clin Exp Allergy (2004) 0.83
Carboxyhemoglobin sources in the metropolitan St. Louis population. Arch Environ Health (1974) 0.83
Recovery from severe arsenic-induced peripheral neuropathy with 2,3-dimercapto-1-propanesulphonic acid. J Toxicol Clin Toxicol (2000) 0.83
Mechanisms of allergic disease - environmental and genetic determinants for the development of allergy. Clin Exp Allergy (2015) 0.80
Colonic lymphoid hyperplasia in melanosis coli. Arch Pathol Lab Med (2001) 0.80
Pregnancy IFN-gamma responses to foetal alloantigens are altered by maternal allergy and gravidity status. Allergy (2008) 0.80
Parallel expression of macrophage metalloelastase (MMP-12) in duodenal and skin lesions of patients with dermatitis herpetiformis. Gut (2001) 0.80
Costimulatory molecules in the developing human gastrointestinal tract: a pathway for fetal allergen priming. J Allergy Clin Immunol (2001) 0.79
[Evaluation of a new association between insulin-sensitizers and α-lipoic acid in obese women affected by PCOS]. Minerva Ginecol (2013) 0.79
Intrahepatic biliary cholesterol and phospholipid transport in humans: effect of obesity and cholesterol cholelithiasis. J Lipid Res (1995) 0.78
Relative stability of a minimal CTG repeat expansion in a large kindred with myotonic dystrophy. Neurology (1998) 0.78
Transmission disequilibrium test of stromelysin-1 gene variation in relation to Crohn's disease. J Med Genet (2004) 0.78
Apoptosis and gastrointestinal tract. Ital J Gastroenterol Hepatol (1999) 0.78
Prevalence of gallstones in patients with primary immunoglobulin deficiency. Evidence for lack of association. Dig Dis Sci (1990) 0.77
Minimal expansion of the GCG repeat in the PABP2 gene does not predispose to sporadic inclusion body myositis. Neurology (1999) 0.77
T cell receptor V beta expression in human intestine: regional variation in postnatal intestine and biased usage in fetal gut. Gut (1996) 0.77
[Treatment with carnitine, acetyl carnitine, L-arginine and ginseng improves sperm motility and sexual health in men with asthenopermia]. Minerva Urol Nefrol (2010) 0.77
Proteolytic enzymes in inflammatory bowel disease. Inflamm Bowel Dis (1998) 0.77
Proximal myotonic myopathy: a syndrome with a favourable prognosis? J Neurol Sci (2002) 0.76
Upregulation of keratinocyte growth factor during T-cell immunity in the gut mucosa. Ann N Y Acad Sci (1998) 0.76
A comparison of the effect of extradural and parenteral analgesia on maternal plasma cortisol concentrations during labour and the puerperium. Br J Obstet Gynaecol (1976) 0.76
Serum regenerating islet-derived 3-alpha is a biomarker of mucosal enteropathies. Aliment Pharmacol Ther (2014) 0.76
Polycystic ovary syndrome (PCOS) and hyperandrogenism: the role of a new natural association. Minerva Ginecol (2015) 0.75
Getting a grip on the myotonic dystrophies. Neurology (1999) 0.75
TOPPER, a software package in FORTRAN for scaling studies. Int J Biomed Comput (1985) 0.75